Vnitr Lek 2012, 58(5):405-410

D vitamin and immunity

I. Šterzl1,2
1 Endokrinologický ústav Praha, ředitelka RNDr. Běla Bendlová, CSc.
2 Ústav imunologie a mikrobiologie, 1. LF UK, přednostka prof. RNDr. Libuše Kolářová, CSc.

Active vitamin D3 is a key factor in many pathological states. In this review its influence on the immune system will be discussed, especially in the scope of innate and adaptive immunity. D3 has a crucial importance in defense against infections and in development of immunopathological reactions, especially in autoimmunity.

Keywords: vitamin D; innate immunity; adaptive immunity; autoimmunity; infections

Received: September 30, 2011; Published: May 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šterzl I. D vitamin and immunity. Vnitr Lek. 2012;58(5):405-410.
Download citation

References

  1. Šterzl I. Přehledná imunoendokrinologie. Praha: Maxdorf 2006.
  2. Mathieu C, Van Etten E, Overbergh L et al. Vitamin D3 in Control of Immune Response. In: Geenen V, Chrousos G (eds). Immunoendocrinology in Health and Disease. New York: Marcel Dekker 2006.
  3. Adams JS, Ren S, Liu PT et al. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009; 182: 4289-4295. Go to original source... Go to PubMed...
  4. Stoffels K, Overbergh L, Giulietti A et al. Immune regulation of 25-hydroxyvitamin-D3-1α-hydroxylase in human monocytes. J Bone Miner Res 2006; 21: 37-47. Go to original source... Go to PubMed...
  5. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010; 39: 365-379. Go to original source... Go to PubMed...
  6. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004; 229: 1136-1142. Go to original source... Go to PubMed...
  7. Wang TT, Nestel FP, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173: 2909-2912. Go to original source... Go to PubMed...
  8. Peric M, Koglin S, Kim SM et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol 2008; 181: 8504-8512. Go to original source... Go to PubMed...
  9. Sadeghi K, Wessner B, Laggner U et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361-370. Go to original source... Go to PubMed...
  10. Albert PJ, Proal AD, Marshall TG. Vitamin D: the alternative hypothesis. Autoimmun Rev 2009; 8: 639-644. Go to original source... Go to PubMed...
  11. Hewison M, Freeman L, Hughes SV et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170: 5382-5390. Go to original source... Go to PubMed...
  12. Karmali R, Hewison M, Rayment N et al. 1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology 1991; 74: 589-593. Go to PubMed...
  13. Mahon BD, Wittke A, Weaver V et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003; 89: 922-932. Go to original source... Go to PubMed...
  14. Topilski I, Flaishon L, Naveh Y et al. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol 2004; 34: 1068-1076. Go to original source... Go to PubMed...
  15. Overbergh L, Decallonne B, Waer M et al. 1 α, 25-dihydroxyvitamin D 3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000; 49: 1301-1307. Go to original source... Go to PubMed...
  16. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006; 18: 349-356. Go to original source... Go to PubMed...
  17. Barrat FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603-616. Go to original source... Go to PubMed...
  18. Urry Z, Xystrakis E, Richards DF et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 2009; 119: 387-398. Go to original source... Go to PubMed...
  19. Meehan TF, DeLuca HF. CD8(+) T cells are not necessary for 1α,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA 2002; 99: 5557-5560. Go to original source... Go to PubMed...
  20. Sigmundsdottir H, Pan J, Debes GF et al. DCs metabolize sunlight-induced vitamin D3 to "program" T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8: 285-293. Go to original source... Go to PubMed...
  21. Lemire JM, Adams JS, Sakai R et al. 1α,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984; 74: 657-661. Go to original source... Go to PubMed...
  22. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-1142. Go to original source... Go to PubMed...
  23. Linker-Israeli M, Elstner E, Klinenberg JR et al. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 2001; 99: 82-93. Go to original source... Go to PubMed...
  24. Ramagopalan SV, Maugeri NJ, Handunnetthi L et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369. Go to original source... Go to PubMed...
  25. Munger KL, Levin LI, Hollis BW et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838. Go to original source... Go to PubMed...
  26. Andjelkovic Z, Vojinovic J, Pejnovic N et al. Disease modifying and immunomodulatory effects of high dose 1α (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999; 17: 453-456. Go to PubMed...
  27. Hyppönen E, Läärä E, Reunanen A et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-1503. Go to original source... Go to PubMed...
  28. Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann N Y Acad Sci 2009; 1173: 384-390. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.